What is the most likely diagnosis and recommended management for a 56‑year‑old female with a 6‑day history of dry cough and nasal congestion that progressed to a small amount of yellow sputum, no fever, normal vital signs, hypertension treated with atenolol and losartan, type 2 diabetes treated with vildagliptin/metformin, and allergic symptoms of itching and epiphora with congested non‑erythematous turbinates?

Most Likely Diagnosis: Post-Viral Upper Airway Cough Syndrome (UACS) with Possible Early Bacterial Superinfection

This patient has post-viral upper airway cough syndrome (UACS) that has progressed from viral rhinitis to productive cough with yellow sputum, though she does not yet meet full criteria for acute bacterial rhinosinusitis. 1

Clinical Reasoning

Why UACS is the Primary Diagnosis

• The 6-day progression from dry cough and watery rhinorrhea to productive cough with yellow sputum is characteristic of post-viral UACS, though the timeline is shorter than the typical 10-14 days required for bacterial superinfection diagnosis 1
• Upper airway cough syndrome (formerly postnasal drip syndrome) is the most common cause of chronic cough in adults, and post-infectious rhinitis is a well-recognized trigger 2
• The congested, non-erythematous turbinates on exam support rhinitis rather than acute sinusitis 1
• Normal vital signs and absence of fever argue against bacterial infection at this stage 1

Allergic Component Present

• The concurrent itching and epiphora (excessive tearing) of the eyes strongly suggest an allergic rhinitis component superimposed on the viral URI 1
• However, the evolution to purulent discharge and absence of classic allergic symptoms (sneezing, seasonal pattern) indicate this is not purely allergic rhinitis 1

Medication-Induced Nasal Congestion Consideration

• Losartan can cause nasal congestion in 2% of patients as a known adverse effect 3, though this typically presents as chronic congestion rather than acute onset with other URI symptoms
• The temporal relationship (acute onset 6 days ago with other viral symptoms) makes medication-induced rhinitis less likely as the primary cause 3

Recommended Management Algorithm

First-Line Treatment (Start Immediately)

Initiate first-generation antihistamine plus decongestant combination therapy:

• Dexbrompheniramine 6 mg + pseudoephedrine 120 mg sustained-release, twice daily 1
• This combination has proven efficacy for post-viral UACS; the anticholinergic effect of first-generation antihistamines reduces non-histamine-mediated rhinitis 1
• Improvement should be expected within days to 2 weeks 1

Alternative if contraindications exist (glaucoma, benign prostatic hyperplasia, severe hypertension):

• Ipratropium bromide nasal spray as directed 1

Avoid newer-generation antihistamines:

• Do not use loratadine, cetirizine, or fexofenadine—these lack anticholinergic activity and are ineffective for post-viral UACS 1

Supportive Measures

• Saline nasal irrigation 2-3 times daily 1—this has no rebound effect unlike topical decongestants
• Ibuprofen 400-600 mg every 6-8 hours as needed for throat discomfort 1
• Increase oral fluid intake (already initiated by patient) 1

When to Add Antibiotics (Not Yet Indicated)

Do NOT start antibiotics at this visit because the patient does not meet criteria for acute bacterial rhinosinusitis:

• Antibiotics require all three of: symptoms >10 days without improvement, purulent nasal discharge, AND facial pain/pressure 1
• This patient is only at day 6 and lacks facial pain/pressure 1
• Viral rhinosinusitis typically resolves within 7-10 days; bacterial superinfection occurs in <2% of cases 1

If symptoms persist beyond 10 days or worsen ("double sickening"):

• Start amoxicillin-clavulanate (covers S. pneumoniae, H. influenzae, M. catarrhalis) for 5-10 days 1

Critical Follow-Up Instructions

Return Immediately If:

• Symptoms persist >10 days without improvement 1
• Symptoms worsen after initial improvement (double sickening pattern) 1
• Development of high fever >39°C with severe unilateral facial pain 1
• Periorbital edema or erythema (suggests orbital complications requiring urgent evaluation) 1
• Severe headache with neck stiffness, vision changes, or mental status changes 1

Scheduled Follow-Up

• Re-evaluate in 2 weeks if no improvement on first-generation antihistamine/decongestant therapy 1
• At that visit, if symptoms persist, obtain:
  • Chest radiograph to rule out pneumonia 1
  • Spirometry to exclude underlying asthma or COPD (especially given morning cough prominence) 1
  • Consider ENT referral for nasal endoscopy if structural abnormalities suspected 1

Important Clinical Pitfalls to Avoid

• Do not assume this is simple allergic rhinitis despite the eye symptoms—the evolution to purulent discharge argues against pure allergic etiology 1
• Do not overlook underlying asthma—persistent cough despite UACS treatment should prompt bronchodilator trial and spirometry 1
• Do not prescribe antibiotics prematurely—only 3 days of symptoms with no "double sickening" pattern indicates viral etiology 1
• Do not use topical decongestants for >3-5 days to avoid rebound congestion (rhinitis medicamentosa) 1
• Monitor for losartan-related cough—while losartan causes less cough than ACE inhibitors (17-29% vs 62-69% in patients with prior ACE-inhibitor cough) 3, postmarketing cases have been reported with positive re-challenge 3

Comorbidity Considerations

• Hypertension on atenolol/losartan: Pseudoephedrine should be used cautiously but is not absolutely contraindicated with normal blood pressure control; monitor BP if concerns arise 1
• Type 2 diabetes on vildagliptin/metformin: No drug interactions with recommended UACS therapy; continue current regimen 4